SHRENA TRAVIS: Open Payments
NPI 1851913255 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 92 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,377 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $223 |
| Lilly USA, LLC | 11 | $169 |
| ABBVIE INC. | 11 | $160 |
| Otsuka America Pharmaceutical, Inc. | 11 | $154 |
| PFIZER INC. | 7 | $152 |
| Abbott Laboratories | 6 | $145 |
| Astellas Pharma US Inc | 5 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Exact Sciences Corporation | 4 | $64 |
Products named: REXULTI, FREESTYLE LIBRE 3, Veozah, MOUNJARO, Kerendia, UBRELVY, Saxenda, Ozempic.
Industry payments across TN — which companies pay providers there.
